GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (FRA:TRB) » Definitions » Shiller PE Ratio

Trinity Biotech (FRA:TRB) Shiller PE Ratio : (As of May. 15, 2024)


View and export this data going back to . Start your Free Trial

What is Trinity Biotech Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Trinity Biotech Shiller PE Ratio Historical Data

The historical data trend for Trinity Biotech's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Shiller PE Ratio Chart

Trinity Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Trinity Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Trinity Biotech's Shiller PE Ratio

For the Diagnostics & Research subindustry, Trinity Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trinity Biotech's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's Shiller PE Ratio falls into.



Trinity Biotech Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Trinity Biotech's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Trinity Biotech's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-13.168/120.1096*120.1096
=-13.168

Current CPI (Dec. 2023) = 120.1096.

Trinity Biotech Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.658 100.573 0.786
201406 0.670 100.773 0.799
201409 0.714 100.474 0.854
201412 0.714 99.576 0.861
201503 0.785 99.975 0.943
201506 0.441 100.573 0.527
201509 0.432 100.274 0.517
201512 0.482 99.676 0.581
201603 -0.260 99.676 -0.313
201606 0.378 101.072 0.449
201609 -0.102 100.274 -0.122
201612 -21.003 99.676 -25.309
201703 0.234 100.374 0.280
201706 0.182 100.673 0.217
201709 0.088 100.474 0.105
201712 -8.573 100.075 -10.289
201803 0.073 100.573 0.087
201806 0.120 101.072 0.143
201809 0.184 101.371 0.218
201812 -5.037 100.773 -6.004
201903 -0.044 101.670 -0.052
201906 -1.146 102.168 -1.347
201909 0.004 102.268 0.005
201912 -5.040 102.068 -5.931
202003 -0.481 102.367 -0.564
202006 -0.311 101.769 -0.367
202009 1.189 101.072 1.413
202012 -1.973 101.072 -2.345
202103 0.298 102.367 0.350
202106 -0.156 103.364 -0.181
202109 0.259 104.859 0.297
202112 -0.266 106.653 -0.300
202203 -2.270 109.245 -2.496
202206 -1.343 112.734 -1.431
202209 -1.187 113.431 -1.257
202212 -1.251 115.425 -1.302
202303 -0.710 117.618 -0.725
202306 -0.720 119.611 -0.723
202309 -0.820 120.708 -0.816
202312 -13.168 120.110 -13.168

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Trinity Biotech  (FRA:TRB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Trinity Biotech Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Trinity Biotech (FRA:TRB) Business Description

Traded in Other Exchanges
Address
IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.

Trinity Biotech (FRA:TRB) Headlines

No Headlines